Literature DB >> 23517079

Is macrocycle a synonym for kinetic inertness in Gd(III) Complexes? Effect of coordinating and noncoordinating substituents on inertness and relaxivity of Gd(III) chelates with DO3A-like ligands.

Miloslav Polasek1, Peter Caravan.   

Abstract

Gadolinium chelates with octadentate ligands are widely used as contrast agents for magnetic resonance imaging (MRI), with macrocyclic ligands based on DO3A being preferred for the high kinetic inertness of their Gd chelates. A major challenge in the design of new bifunctional MRI probes is the need to control the rotational motion of the chelate, which greatly affects its relaxivity. In this work we explored facile alkylation of a secondary amine in macrocyclic DO3A-like ligands to create a short, achiral linkage to limit the undesired internal motion of chelates within larger molecular constructs. The acetate moiety on the trans nitrogen was also replaced with either a bidentate (ethoxyacetate, L1 or methyl picolinate, L2) or bulky monodentate (methyl phosphonate, L3) donor arm to give octa- or heptadentate ligands, respectively. The resultant Gd(III) complexes were all monohydrated (q = 1) and exhibited water residency times that spanned 2 orders of magnitude (τM = 2190 ± 170, 3500 ± 90, and 12.7 ± 3.8 ns at 37 °C for GdL1, GdL2, and GdL3, respectively). Alkylation of the secondary amine with a noncoordinating biphenyl moiety resulted in coordinatively saturated q = 0 complexes of octadentate ligands L1 and L2. Relaxivities were limited by slow water exchange and/or lack of water coligand. All complexes showed decreased inertness compared to [Gd(DO3A)] despite higher ligand denticity, and inertness was further decreased upon N-alkylation. These results demonstrate that high kinetic inertness and in vivo safety of Gd chelates with macrocyclic ligands should not be generalized.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23517079      PMCID: PMC3640422          DOI: 10.1021/ic400227k

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  52 in total

1.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Authors:  Thomas Grobner
Journal:  Nephrol Dial Transplant       Date:  2006-01-23       Impact factor: 5.992

2.  Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.

Authors:  Peter Caravan
Journal:  Acc Chem Res       Date:  2009-07-21       Impact factor: 22.384

3.  Unexpected aggregation of neutral, xylene-cored dinuclear GdIII chelates in aqueous solution.

Authors:  Jérôme Costa; Edina Balogh; Véronique Turcry; Raphaël Tripier; Michel Le Baccon; Françoise Chuburu; Henri Handel; Lothar Helm; Eva Tóth; André E Merbach
Journal:  Chemistry       Date:  2006-09-06       Impact factor: 5.236

4.  Synthesis, complexation and NMR relaxation properties of Gd3+ complexes of Mes(DO3A)3.

Authors:  Pascal Miéville; Hugues Jaccard; Felipe Reviriego; Raphaël Tripier; Lothar Helm
Journal:  Dalton Trans       Date:  2011-03-31       Impact factor: 4.390

5.  Lanthanide complexes based on a diazapyridinophane platform containing picolinate pendants.

Authors:  Adrián Roca-Sabio; Célia S Bonnet; Marta Mato-Iglesias; David Esteban-Gómez; Éva Tóth; Andrés de Blas; Teresa Rodríguez-Blas; Carlos Platas-Iglesias
Journal:  Inorg Chem       Date:  2012-09-27       Impact factor: 5.165

6.  High relaxivity magnetic resonance imaging contrast agents. Part 1. Impact of single donor atom substitution on relaxivity of serum albumin-bound gadolinium complexes.

Authors:  Stéphane Dumas; Vincent Jacques; Wei-Chuan Sun; Jeffrey S Troughton; Joel T Welch; Jaclyn M Chasse; Heribert Schmitt-Willich; Peter Caravan
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

7.  Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions.

Authors:  Martin A Sieber; Philipp Lengsfeld; Thomas Frenzel; Sven Golfier; Heribert Schmitt-Willich; Fred Siegmund; Jakob Walter; Hanns-Joachim Weinmann; Hubertus Pietsch
Journal:  Eur Radiol       Date:  2008-06-11       Impact factor: 5.315

8.  NMR relaxometric study of new Gd(III) macrocyclic complexes and their interaction with human serum albumin.

Authors:  Mauro Botta; Silvio Quici; Gianluca Pozzi; Giovanni Marzanni; Roberto Pagliarin; Serena Barra; Simonetta Geninatti Crich
Journal:  Org Biomol Chem       Date:  2004-01-21       Impact factor: 3.876

9.  Hydrogels incorporating GdDOTA: towards highly efficient dual T1/T2 MRI contrast agents.

Authors:  Thomas Courant; Valérie Gaëlle Roullin; Cyril Cadiou; Maïté Callewaert; Marie Christine Andry; Christophe Portefaix; Christine Hoeffel; Marie Christine de Goltstein; Marc Port; Sophie Laurent; Luce Vander Elst; Robert Muller; Michaël Molinari; Françoise Chuburu
Journal:  Angew Chem Int Ed Engl       Date:  2012-08-02       Impact factor: 15.336

10.  Monopropionate analogues of DOTA4- and DTPA5-: kinetics of formation and dissociation of their lanthanide(III) complexes.

Authors:  Edina Balogh; Raphaël Tripier; Petra Fousková; Felipe Reviriego; Henri Handel; Eva Tóth
Journal:  Dalton Trans       Date:  2007-06-26       Impact factor: 4.390

View more
  13 in total

1.  Removal of gadolinium-based contrast agents: adsorption on activated carbon.

Authors:  María P Elizalde-González; Esmeralda García-Díaz; Mario González-Perea; Jürgen Mattusch
Journal:  Environ Sci Pollut Res Int       Date:  2017-01-31       Impact factor: 4.223

2.  Amplifying the sensitivity of zinc(II) responsive MRI contrast agents by altering water exchange rates.

Authors:  Jing Yu; André F Martins; Christian Preihs; Veronica Clavijo Jordan; Sara Chirayil; Piyu Zhao; Yunkou Wu; Khaled Nasr; Garry E Kiefer; A Dean Sherry
Journal:  J Am Chem Soc       Date:  2015-10-29       Impact factor: 15.419

3.  [Gd(CyPic3A)(H2O)2]-: a stable, bis(aquated) and high-relaxivity Gd(III) complex.

Authors:  Eric M Gale; Nathaniel Kenton; Peter Caravan
Journal:  Chem Commun (Camb)       Date:  2013-08-01       Impact factor: 6.222

Review 4.  MR imaging probes: design and applications.

Authors:  Eszter Boros; Eric M Gale; Peter Caravan
Journal:  Dalton Trans       Date:  2015-03-21       Impact factor: 4.390

5.  Probing the structure-relaxivity relationship of bis-hydrated Gd(DOTAla) derivatives.

Authors:  Eszter Boros; Peter Caravan
Journal:  Inorg Chem       Date:  2015-02-18       Impact factor: 5.165

6.  Rapid synthesis of 1,7-bis(t-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane (DO2A-t-Bu ester).

Authors:  Lauren E Hopper; Matthew J Allen
Journal:  Tetrahedron Lett       Date:  2014-10-01       Impact factor: 2.415

Review 7.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

Review 8.  Enhancing magnetic resonance imaging with contrast agents for ultra-high field strengths.

Authors:  Akhila N W Kuda-Wedagedara; Matthew J Allen
Journal:  Analyst       Date:  2014-09-21       Impact factor: 4.616

9.  A DNA-Based MRI Contrast Agent for Quantitative pH Measurement.

Authors:  Hyewon Seo; Kristine Y Ma; Erin E Tuttle; Isen Andrew C Calderon; Alissa D Buskermolen; Chris A Flask; Heather A Clark
Journal:  ACS Sens       Date:  2021-02-24       Impact factor: 9.618

Review 10.  Strategies for optimizing water-exchange rates of lanthanide-based contrast agents for magnetic resonance imaging.

Authors:  Buddhima N Siriwardena-Mahanama; Matthew J Allen
Journal:  Molecules       Date:  2013-08-05       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.